A one day Science Symposium: celebration of 20 years of ExcellGene

 At the heart of this publication, entitled “A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology” and co-authored by Pfizer, Magellan Biologics, and

Proud moment for Magellan Biologics & Consulting !Following the recent publication in Antibodies – based on Pfizer’s outstanding experimental work and co-authored with Magellan Biologics